Advertisement

The Scientist

» biotech

Most Recent

image: Opinion: AIA Does Not Discriminate

Opinion: AIA Does Not Discriminate

By | August 21, 2013

The America Invents Act (AIA) was a step in the right direction for US competitiveness and open innovation.

5 Comments

image: BPTW: By The Numbers

BPTW: By The Numbers

By | June 1, 2013

Take a closer look at some of the statistics generated by The Scientist's Best Place to Work Industry 2013 survey.

0 Comments

image: Best Places to Work Industry 2013

Best Places to Work Industry 2013

By | June 1, 2013

Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.

1 Comment

image: Start It Up

Start It Up

By | April 1, 2013

Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.

1 Comment

image: Philip Low: Sleep Analyzer

Philip Low: Sleep Analyzer

By | January 1, 2013

Founder, Chairman, and CEO, NeuroVigil, Age: 33

2 Comments

image: Single Patent for EU

Single Patent for EU

By | December 12, 2012

After decades of political wrangling, the European Union is poised to introduce a single patent system to reduce red tape and application costs for researchers and companies.

1 Comment

image: DNA for the Masses

DNA for the Masses

By | October 31, 2012

An Israeli company plans to synthesize DNA on demand for anyone, including those outside of research labs.  

1 Comment

image: IP Lawsuits Settled

IP Lawsuits Settled

By | September 5, 2012

Two lawsuits against prominent researcher Craig Thompson for allegedly failing to share intellectual property with his institution lead to a licensing agreement on cancer diagnostics.

0 Comments

image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

0 Comments

image: Opinion: On the Up and Up

Opinion: On the Up and Up

By | June 20, 2012

An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.

5 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
BioTek
BioTek
Advertisement
The Scientist
The Scientist